Details werden geladen...
Profound Medical Corp. (PRN.TO) Stock: Advances as Study Shows TULSA Outperforms Robotic Surgery on Key Quality-of-Life Measures
Profound Medical stock climbed over 8% after new CAPTAIN trial data showed the TULSA Procedure preserved penile length better than robotic surgery.